Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Anthropic says Claude has supported drug design, laboratory analysis, regulatory documentation, and clinical trial planning in projects with six life sciences organizations.
UnitedHealthcare is expanding access to its Avery generative AI assistant from about 6.7 million members to 21 million. The insurer says Avery resolves 90% of member interactions without human support.
Swiss biotech startup Atlas Bio raised $12.5 million to develop an AI model that simulates drug efficacy and safety in virtual patients.
University of Leeds spinout adsilico raised £10 million to expand its virtual patient technology for testing medical devices before clinical trials.
Vera Health raised a $28.5 million Series A to expand its clinical evidence search platform, which is used by more than 800,000 clinicians across 190 countries.
Baba, an AI care company for Medicare and Medicaid patients, raised a $40 million Series A led by FirstMark.
Google Research is expanding tuberculosis screening tools based on chest X rays, cough audio and open models. Its technology supports clinical deployments in Africa and a national screening program in Indonesia.
Lunit and Summit Therapeutics will use the Lunit SCOPE IO pathology platform to analyze tumor tissue images for research involving ivonescimab.
Pathos AI raised $237 million in a Series E round led by Bristol Myers Squibb. The company will expand its Foundry AI platform and advance four oncology drug candidates.
BioVid has launched Mimetics, a research platform that models how physicians assess evidence and make treatment decisions. The company says validation tests found an 80% to 90% match between synthetic and human physician groups.
Draft NICE guidance recommends five AI tools for NHS use during a two year evidence collection period. The software highlights possible cancer on prostate MRI scans for review by radiologists.
Boehringer Ingelheim and Microsoft will study Digital Patient Twins for clinical development, starting with lung health.
The FDA has cleared AVIEW Aorta Metrics, which automatically segments the aorta and measures its diameter from chest CT images.
Ping An Good Doctor reported RMB 250 million in net profit for the first nine months of 2026, while its AI Doctor service reached nearly 13 million users.
BioStack raised $9.5 million in seed funding and launched a data network covering more than 100 million de identified patient records across four countries.
Former OpenAI science lead Kevin Weil launched Warp Sciences with $215 million in funding at an $865 million valuation. The startup will train robots to make and test compounds for drug discovery.
Tufts Medicine will use Humata Health to process prior authorization requests for select imaging services provided to Blue Cross Blue Shield of Massachusetts members.
Phylo will provide Bayer scientists with access to Biomni Lab for drug discovery workflows involving scientific literature, biomedical data and omics evidence.
Eko Health has launched the FDA cleared CORE 300 stethoscope, which combines analog listening with digital amplification, noise cancellation and optional AI analysis.
AgentixCare uses AI agents for clinical documentation, prior authorization, claims management and connected medical devices, with human review for critical actions.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
